Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?

Heart disease remains a leading cause of mortality and a major worldwide healthcare burden. Recent advances in stem cell biology have made it feasible to derive large quantities of cardiomyocytes for disease modeling, drug development, and regenerative medicine. The discoveries of reprogramming and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebert, Antje D, Diecke, Sebastian, Chen, Ian Y, Wu, Joseph C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568945/
https://www.ncbi.nlm.nih.gov/pubmed/26183451
http://dx.doi.org/10.15252/emmm.201504395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568945/
https://www.ncbi.nlm.nih.gov/pubmed/26183451
http://dx.doi.org/10.15252/emmm.201504395

Ejemplares similares